{"id":"disodium-edta","safety":{"commonSideEffects":[{"rate":null,"effect":"Nephrotoxicity / acute kidney injury"},{"rate":null,"effect":"Hypocalcemia"},{"rate":null,"effect":"Hypomagnesemia"},{"rate":null,"effect":"Zinc depletion"},{"rate":null,"effect":"Infusion site reactions"}]},"_chembl":{"chemblId":"CHEMBL1200375","moleculeType":"Small molecule","molecularWeight":"374.27"},"_dailymed":{"setId":"3415fb52-47c5-0715-e063-6294a90a272c","title":"THE MELANIN SKIN PROTECTANT CREAM (PURIFIED WATER, GLYCERIN, PROPYLENE GLYCOL, LAUROCAPRAM, NIACINAMIDE, XANTHAN GUM, BUTYLENE GLYCOL, TOCOPHEROL, CETEARYL ALCOHOL, ISOHEXADECANE, ETHYLHEXYL PALMITATE, CAPRYLIC/CAPRIC TRIGLYCERIDE, HYDROGENATED LECITHIN, CETEARYL GLUCOSIDE, POLYACRYLAMIDE, C13-14 ISOPARAFFIN, 1,2-HEXANEDIOL, DISODIUM EDTA, ERGOTHIONEINE, SELAGINELLA TAMARISCINA EXTRACT, ETHYLHEXYLGLYCERIN, GLUCOSE, FRAGRANCE, GINKGO BILOBA LEAF EXTRACT, PRUNELLA VULGAIRS EXTRACT, CROTON LECHLERI RESIN EXTRACT) CREAM [REEDFRESH CO., LTD]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"EDTA (ethylenediaminetetraacetic acid) forms stable complexes with metal ions such as lead, cadmium, and calcium, facilitating their urinary excretion. It is used clinically to treat heavy metal poisoning and hypercalcemia by reducing circulating levels of these ions.","oneSentence":"Disodium EDTA is a chelating agent that binds and removes heavy metals and excess divalent cations from the bloodstream.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:36.229Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Lead poisoning (plumbism)"},{"name":"Hypercalcemia"},{"name":"Heavy metal toxicity (cadmium, zinc)"}]},"trialDetails":[{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT06750653","phase":"PHASE4","title":"Skin Barrier Function and Inflammation in Aging: The BIA Study","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-02-06","conditions":"Inflammation, Skin Inflammation, Aging","enrollment":32},{"nctId":"NCT03630991","phase":"PHASE1","title":"Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-10-11","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive","enrollment":58},{"nctId":"NCT07267013","phase":"PHASE2","title":"Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)","status":"NOT_YET_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-03-30","conditions":"Aortic Surgery, Extracorporeal Circulation","enrollment":25},{"nctId":"NCT06716021","phase":"PHASE3","title":"ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3","status":"NOT_YET_RECRUITING","sponsor":"Milestone Pharmaceuticals Inc.","startDate":"2027-01","conditions":"Atrial Fibrillation","enrollment":750},{"nctId":"NCT06016088","phase":"PHASE1, PHASE2","title":"A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection","status":"RECRUITING","sponsor":"Respirion Pharmaceuticals Pty Ltd","startDate":"2024-04-01","conditions":"Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa","enrollment":72},{"nctId":"NCT02156739","phase":"NA","title":"Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-10-13","conditions":"Hepatocellular Carcinoma, Liver and Intrahepatic Bile Duct Disorder, Metastatic Malignant Neoplasm in the Liver","enrollment":100},{"nctId":"NCT04681066","phase":"PHASE2","title":"A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2021-03-24","conditions":"Acute Pancreatitis, Systemic Inflammatory Response Syndrome","enrollment":216},{"nctId":"NCT05501756","phase":"PHASE2","title":"Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-01-11","conditions":"Allogeneic Hematopoietic Cell Transplantation","enrollment":60},{"nctId":"NCT02733185","phase":"PHASE3","title":"Trial to Assess Chelation Therapy 2","status":"COMPLETED","sponsor":"Mt. Sinai Medical Center, Miami","startDate":"2016-10-01","conditions":"Diabetes, Myocardial Infarction","enrollment":1000},{"nctId":"NCT05057897","phase":"PHASE4","title":"A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2022-01-31","conditions":"COVID-19, SARS-CoV-2","enrollment":34},{"nctId":"NCT04829344","phase":"PHASE3","title":"A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution","status":"COMPLETED","sponsor":"American Genomics, LLC","startDate":"2021-03-30","conditions":"Anesthesia, Local","enrollment":120},{"nctId":"NCT05846568","phase":"PHASE3","title":"Study to Evaluate GR1801's Efficacy and Safety","status":"COMPLETED","sponsor":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","startDate":"2022-10-21","conditions":"Rabies Post-exposure Prophylaxis","enrollment":1200},{"nctId":"NCT04973449","phase":"PHASE2, PHASE3","title":"Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-06-27","conditions":"COVID-19, SARS-CoV-2","enrollment":2843},{"nctId":"NCT04467905","phase":"PHASE2","title":"ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2","status":"COMPLETED","sponsor":"Milestone Pharmaceuticals Inc.","startDate":"2020-11-19","conditions":"Atrial Fibrillation","enrollment":69},{"nctId":"NCT03982693","phase":"PHASE3","title":"Trial to Assess Chelation Therapy in Critical Limb Ischemia","status":"RECRUITING","sponsor":"Mt. Sinai Medical Center, Miami","startDate":"2019-03-19","conditions":"Critical Limb Ischemia, Diabetes","enrollment":50},{"nctId":"NCT06178367","phase":"PHASE3","title":"Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2023-08-26","conditions":"Xerosis Cutis","enrollment":36},{"nctId":"NCT06370260","phase":"NA","title":"Assessing the Efficacy of a Hydrogen Peroxide Gel for Oral Wound Healing and Oral Hygiene","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2023-05-02","conditions":"Wound Heal, Postoperative Pain, Biopsy Wound","enrollment":54},{"nctId":"NCT06175923","phase":"","title":"Role of BMP Pathway in MDS Progression","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-01-27","conditions":"Myelodysplastic Syndromes, Acute Myelogenous Leukemia","enrollment":60},{"nctId":"NCT02798523","phase":"PHASE1","title":"Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-01-24","conditions":"Normal Physiology","enrollment":33},{"nctId":"NCT04290039","phase":"PHASE1","title":"Sublingual vs IV Atropine Bioavailability Study","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2020-01-04","conditions":"Toxic Effect of Organophosphate and Carbamate Insecticides","enrollment":15},{"nctId":"NCT03141983","phase":"PHASE2","title":"Anti-Cytokine Therapy for Hemodialysis InflammatION","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-12-15","conditions":"End-Stage Renal Disease","enrollment":80},{"nctId":"NCT05715944","phase":"PHASE3","title":"Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2","status":"COMPLETED","sponsor":"Botswana Harvard AIDS Institute Partnership","startDate":"2021-09-15","conditions":"COVID-19","enrollment":10888},{"nctId":"NCT03467932","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Oramed, Ltd.","startDate":"2018-05-29","conditions":"T2DM (Type 2 Diabetes Mellitus)","enrollment":373},{"nctId":"NCT02592551","phase":"PHASE2","title":"MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2016-05-11","conditions":"Mesothelioma","enrollment":24},{"nctId":"NCT04513652","phase":"PHASE3","title":"A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution","status":"COMPLETED","sponsor":"American Genomics, LLC","startDate":"2020-09-03","conditions":"Anesthesia, Local","enrollment":120},{"nctId":"NCT05475314","phase":"NA","title":"Effect of Postbiotic Product on Colonic Barriers in IBS","status":"COMPLETED","sponsor":"Nordisk Rebalance A/S","startDate":"2020-12-01","conditions":"IBS - Irritable Bowel Syndrome","enrollment":30},{"nctId":"NCT05071742","phase":"","title":"Correlation of Genetic Susceptibility Genes to Inflammatory Bowel Disease in Chinese Han Population","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2021-11-25","conditions":"Gene Abnormality, Inflammatory Bowel Disease, Chinese","enrollment":500},{"nctId":"NCT04566549","phase":"PHASE2","title":"The Safety and Efficacy Evaluation of Hair Products Containing Probiotics","status":"COMPLETED","sponsor":"GenMont Biotech Incorporation","startDate":"2020-07-06","conditions":"Skin Problems","enrollment":21},{"nctId":"NCT03991520","phase":"EARLY_PHASE1","title":"Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms","status":"UNKNOWN","sponsor":"University of California, San Diego","startDate":"2020-06-16","conditions":"Endometriosis, Anakinra, Markers of Inflammation","enrollment":20},{"nctId":"NCT04846361","phase":"NA","title":"Vaginal Hygiene Wash as Adjunct Treatment in Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2021-05","conditions":"Bacterial Vaginoses","enrollment":56},{"nctId":"NCT02833974","phase":"PHASE2","title":"Effect of the GSK2245035 on the Allergen-induced Asthmatic Response","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-12-05","conditions":"Asthma","enrollment":36},{"nctId":"NCT04519788","phase":"PHASE1","title":"AT-301 Nasal Spray in Healthy Adults","status":"COMPLETED","sponsor":"Atossa Therapeutics, Inc.","startDate":"2020-08-07","conditions":"Healthy","enrollment":32},{"nctId":"NCT03380754","phase":"NA","title":"Effects of Preoperative Carbohydrate Rich Drinks on Immediate Postoperative Outcome in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2017-07-15","conditions":"Post Operative Nausea and Vomiting","enrollment":150},{"nctId":"NCT03302754","phase":"NA","title":"Precision Dosing of Alemtuzumab","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2017-10-05","conditions":"Allogeneic Hematopoietic Cell Transplantation","enrollment":12},{"nctId":"NCT03477422","phase":"PHASE3","title":"CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2014-01-11","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":230},{"nctId":"NCT03424746","phase":"EARLY_PHASE1","title":"Chelation Therapy in Diabetic Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"Mt. Sinai Medical Center, Miami","startDate":"2015-08","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease","enrollment":11},{"nctId":"NCT03043534","phase":"NA","title":"Pre-Shave Gel and Brush in Pseudofolliculitis Barbae","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2015-11-12","conditions":"Pseudofolliculitis Barbae","enrollment":29},{"nctId":"NCT03707678","phase":"PHASE2","title":"A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2019-01-21","conditions":"Asthma","enrollment":""},{"nctId":"NCT02286258","phase":"PHASE1, PHASE2","title":"Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2014-10","conditions":"Renal Insufficiency, Chronic, Kidney Diseases","enrollment":166},{"nctId":"NCT02248051","phase":"PHASE1","title":"Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury","status":"COMPLETED","sponsor":"Complexa, Inc.","startDate":"2014-09","conditions":"Acute Kidney Injury (Nontraumatic)","enrollment":12},{"nctId":"NCT02127190","phase":"PHASE1","title":"Study of CXA-10 in Healthy Volunteers","status":"COMPLETED","sponsor":"Complexa, Inc.","startDate":"2014-04","conditions":"Acute Kidney Injury (Nontraumatic)","enrollment":30},{"nctId":"NCT02421029","phase":"PHASE4","title":"Prolonged Gadolinium Retention After MRI Imaging","status":"WITHDRAWN","sponsor":"Mt. Sinai Medical Center, Miami","startDate":"2017-07","conditions":"Heavy Metal Toxicity","enrollment":""},{"nctId":"NCT01607372","phase":"PHASE2","title":"A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-04","conditions":"Asthma and Rhinitis","enrollment":18},{"nctId":"NCT02677610","phase":"PHASE3","title":"Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older","status":"WITHDRAWN","sponsor":"Merz North America, Inc.","startDate":"","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT02677636","phase":"PHASE3","title":"Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older","status":"WITHDRAWN","sponsor":"Merz North America, Inc.","startDate":"","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT01562093","phase":"NA","title":"Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2012-01","conditions":"Asthma","enrollment":14},{"nctId":"NCT01539343","phase":"PHASE2","title":"Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-04","conditions":"Infection","enrollment":31},{"nctId":"NCT02578602","phase":"PHASE1","title":"MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2010-10","conditions":"Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, BCLC Stage 0 Adult Hepatocellular Carcinoma","enrollment":26},{"nctId":"NCT02508350","phase":"NA","title":"The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock","status":"UNKNOWN","sponsor":"Zhongda Hospital","startDate":"2015-01","conditions":"Septic Shock","enrollment":12},{"nctId":"NCT02245945","phase":"PHASE1","title":"Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females","status":"WITHDRAWN","sponsor":"CONRAD","startDate":"","conditions":"HIV Prevention","enrollment":""},{"nctId":"NCT01421368","phase":"PHASE1","title":"Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-03","conditions":"HIV Prevention","enrollment":72},{"nctId":"NCT01575418","phase":"PHASE1","title":"An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations","status":"COMPLETED","sponsor":"Ian McGowan","startDate":"2013-03","conditions":"HIV Prevention","enrollment":9},{"nctId":"NCT01369303","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-01","conditions":"Prevention","enrollment":194},{"nctId":"NCT00105534","phase":"PHASE3","title":"Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-07","conditions":"Bacterial Conjunctivitis","enrollment":685},{"nctId":"NCT01575405","phase":"PHASE1","title":"A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally","status":"COMPLETED","sponsor":"Ian McGowan","startDate":"2013-03","conditions":"HIV Prevention","enrollment":13},{"nctId":"NCT01695187","phase":"PHASE3","title":"NB-001 Treatment of Recurrent Herpes Labialis","status":"UNKNOWN","sponsor":"NanoBio Corporation","startDate":"2012-10","conditions":"Herpes Labialis","enrollment":362},{"nctId":"NCT01101412","phase":"PHASE1, PHASE2","title":"Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"","conditions":"Chronic Myeloproliferative Disorders, Infection, Leukemia","enrollment":""},{"nctId":"NCT00378781","phase":"NA","title":"Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"","conditions":"Cancer","enrollment":""},{"nctId":"NCT00874887","phase":"PHASE4","title":"A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-03","conditions":"Anti-biotic Resistance","enrollment":66},{"nctId":"NCT00227409","phase":"NA","title":"Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2001-11","conditions":"Urologic Disease","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":254,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["EDTA","Edetic Acid, Calcium, Sodium Salt","Edetate Disodium Calcium","chelation therapy"],"phase":"marketed","status":"active","brandName":"disodium EDTA","genericName":"disodium EDTA","companyName":"Mt. Sinai Medical Center, Miami","companyId":"mt-sinai-medical-center-miami","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Disodium EDTA is a chelating agent that binds and removes heavy metals and excess divalent cations from the bloodstream. Used for Lead poisoning (plumbism), Hypercalcemia, Heavy metal toxicity (cadmium, zinc).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}